Novabay Pharmaceuticals Inc

ASE:NBY   2:35:53 PM EDT
1.66
-0.08 (-4.60%)
Earnings Announcements

Novabay Pharmaceuticals Reports Third Quarter 2022 Financial Results

Published: 11/14/2022 21:23 GMT
Novabay Pharmaceuticals Inc (NBY) - Novabay Pharmaceuticals Reports Third Quarter 2022 Financial Results.
Novabay Pharmaceuticals Inc - Qtrly Loss per Share $0.10.
Revenue is expected to be $4.73 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $4.23 Million
Next Quarter EPS Guidance is expected to be -$0.27

More details on our Analysts Page.